[APLS] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
19-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -88.04%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 250,646 0 0 0 0 0 0 -
PBT -343,029 -304,707 -127,502 -51,006 -27,125 -46,516 -11,232 76.70%
Tax 1,845 5,109 -533 251 -27,282 -26,537 -443 -
NP -344,874 -309,816 -127,502 -51,006 -27,125 -46,516 -10,788 78.05%
Tax Rate - - - - - - - -
Total Cost 595,520 309,816 127,502 51,006 27,125 46,516 10,788 95.01%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -137.59 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -4.59 -4.98 -2.34 -3.68 -1.50 -2.57 -0.60 40.32%
EPS Diluted -4.59 -4.98 -2.34 -3.68 -1.50 -2.57 -0.60 40.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.